# Aprepitant

NDC: 68462-583
Generic name: Aprepitant
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20171012

FDA application: ANDA207777

## Active ingredients

- APREPITANT: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-583"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-583
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d72e0e10-4557-41b0-b65d-d395468cad19